Novavax, Inc.
NVAX
|
$3.99
-3.16%
-3.26%
3.7M
|
Health Technology
(0.0% 1d) (-19.8% 1m) (-56.4% 1y) (0.0% 2d) (0.0% 3d) (-3.3% 7d) (32.9% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 558,413,041
http://www.novavax.com
Sec Filling | Patents | 165 employees
(US) Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
vaccine infectious disease msa
add to watch list Paper trade email alert is off
Press-releases
Labaton Keller Sucharow LLP Announces Proposed Settlement on Behalf of Purchasers of Lordstown Motors Corp. Securities - RIDE RIDEW
Published: 2024-04-05 (Crawled : 13:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -4.77%
H: 3.3%
C: 0.68%
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Published: 2024-04-01 (Crawled : 12:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -1.03%
H: 0.62%
C: -3.53%
covid-19 candidate vaccine congress world
Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP Announce Notice of Pendency of Stockholder Class Actions and Proposed Settlement for All Record and Beneficial Owners of Pattern Energy Group Inc. Common Stock as of March 16, 2020
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -0.95%
H: 2.48%
C: -1.91%
energy group
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
Published: 2024-02-29 (Crawled : 21:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 3.04%
H: 8.06%
C: 5.89%
conference health care
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-02-28 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -22.92%
H: 1.29%
C: -4.96%
year financial results
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
Published: 2024-02-22 (Crawled : 11:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 12.06%
H: 22.42%
C: 9.42%
covid-19 vaccine reach agreement
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 0.0%
H: 1.68%
C: -0.72%
conference year financial results
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 15:30) - biospace.com/
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: -2.2%
conference
Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
Published: 2023-12-05 (Crawled : 21:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 0.18%
H: 3.93%
C: -0.36%
covid-19 authorized vaccine canada
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
Published: 2023-11-28 (Crawled : 11:00) - prnewswire.com
NVAX | $3.99 -3.16% -3.26% 3.7M
|
Health Technology
|
| O: 1.1%
H: 5.07%
C: 3.8%
covid-19 vaccine health world
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Last 48 Hours Insiders Buying
KFS P 481 | $8.6 1.06% 0.0% 15K
|
Finance
|
20:30
AINC | $4.83 -1.43% -1.04% 81K
|
Finance
|
20:30
RVP P 3587 | $1.065 -1.39% 0.47% 49K
|
Health Technology
|
17:00
TPL P 12 | $586.93 0.52% 0.0% 50K
|
Miscellaneous
|
16:01
HNRA | $2.76 16.95% -1.81% 400K
|
n/a
|
15:02
TGEN | $0.67 39.71% 16K
|
Utilities
|
14:30
RMCF | $3.6492 -7.2% 9.2K
|
Consumer Non-Durables
|
20:10